| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | Director | Common Stock | 41,666 | $1,040,450 | $24.97 | 12 Sep 2025 | By Paul Capital Strategy III Fund LLC |
| ALNYLAM PHARMACEUTICALS, INC. | Director | Common Stock | 1,000 | $185,320 | $185.32 | 01 Apr 2022 | Direct |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Direct |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Jann E. Paul GRAT III |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Jann E Paul Revocable Trust |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Steve M. Paul Family 2021 Delaware Trust |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | Steven M. Paul Family 2024 Trust |
| Karuna Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $330.00 | 18 Mar 2024 | The Steven M Paul Revocable Trust |
| Karuna Therapeutics, Inc. | Director | Option (right to buy) | 0 | $0 | $142.74 | 18 Mar 2024 | Direct |
| Rapport Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 21,850 | 17 Jun 2025 | Direct | ||
| Voyager Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15,000 | 03 Jun 2021 | Direct | ||
| Sage Therapeutics, Inc. | Director | Stock Options (Right to buy) | 3,971 | 03 Jan 2024 | Direct | ||
| ALNYLAM PHARMACEUTICALS, INC. | Director | Non-Qualified Stock Option (right to buy) | 0 | 01 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | 12 Sep 2025 | 2 | +$1,027,111 | 4 | Director | 15 Sep 2025, 16:05 |
| RAPP | Rapport Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:15 |
| RAPP | Rapport Therapeutics, Inc. | 06 Jun 2024 | 0 | $0 | 3 | Director | 06 Jun 2024, 18:51 |
| KRTX | Karuna Therapeutics, Inc. | 18 Mar 2024 | 18 | -$829,620,123 | 4 | Director | 18 Mar 2024, 16:30 |
| KRTX | Karuna Therapeutics, Inc. | 29 Feb 2024 | 7 | +$14,932,598 | 4 | Director | 04 Mar 2024, 17:34 |
| KRTX | Karuna Therapeutics, Inc. | 23 Feb 2024 | 4 | +$599,675 | 4 | Director | 26 Feb 2024, 18:15 |
| KRTX | Karuna Therapeutics, Inc. | 09 Feb 2024 | 1 | -$254,981 | 4 | Director | 12 Feb 2024, 17:13 |
| SAGE | Sage Therapeutics, Inc. | 03 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:07 |
| SAGE | Sage Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 16 Jun 2023, 16:06 |
| KRTX | Karuna Therapeutics, Inc. | 09 Feb 2023 | 6 | $0 | 4 | CSO and President of R&D, Director | 13 Feb 2023, 15:15 |
| SAGE | Sage Therapeutics, Inc. | 04 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:30 |
| SAGE | Sage Therapeutics, Inc. | 28 Nov 2022 | 1 | +$191 | 4 | Director | 30 Nov 2022, 15:15 |
| SAGE | Sage Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:35 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 01 Apr 2022 | 12 | -$2,390,421 | 4 | Director | 05 Apr 2022, 16:05 |
| KRTX | Karuna Therapeutics, Inc. | 16 Feb 2022 | 1 | $0 | 4 | President & CEO, Director | 17 Feb 2022, 16:20 |
| SAGE | Sage Therapeutics, Inc. | 04 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:08 |
| SAGE | Sage Therapeutics, Inc. | 09 Nov 2021 | 1 | +$43.36 | 4 | Director | 12 Nov 2021, 15:53 |
| KRTX | Karuna Therapeutics, Inc. | 17 Aug 2021 | 2 | +$250,264 | 4 | PRESIDENT & CEO, Director | 18 Aug 2021, 19:43 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | 15 Jul 2021 | 1 | $0 | 4 | Director | 19 Jul 2021, 16:20 |
| SAGE | Sage Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:08 |
| VYGR | Voyager Therapeutics, Inc. | 03 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 16:34 |